What is INO (INO) stock price today?

INO (INO) is currently trading at $1.04, up 0.97% today.

What is INO P/E ratio?

INO's P/E ratio is -2.73. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is INO return on equity (ROE)?

INO's return on equity (ROE) is -296.36%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is INO's market cap?

INO has a market capitalization of $55.73M.

NASDAQ · Biotechnology

INO (INO) Stock

$1.04 +0.97% NASDAQ: INO Healthcare

Valuation

Metric	Value
Price	$1.04
Market Cap	$55.73M
P/E Ratio	-2.73
P/B Ratio	15.14
P/S Ratio	2122.74
EPS (TTM)	$-0.58
52-Week High	$2.98
52-Week Low	$0.97
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-296.36%
ROA	-76.36%
ROCE	-362.50%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	1.43
Current Ratio	1.39

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$2.0M	$10.0M	$1.0M	$0	$0
Operating Profit	$-301.0M	$-268.0M	$-144.0M	$-112.0M	$-87.0M
Net Profit	$-304.0M	$-280.0M	$-135.0M	$-107.0M	$-85.0M
EPS	$-1.42	$-14.07	$-6.09	$-3.95	$-1.81
Op Margin	-16972.3%	-2607.3%	-17300.3%	-51616.9%	-132871.3%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$496.0M	$349.0M	$171.0M	$113.0M	$74.0M
Total Liabilities	$96.0M	$126.0M	$54.0M	$45.0M	$50.0M
Cash	$71.0M	$46.0M	$14.0M	$66.0M	$44.0M
Borrowings	$33.0M	$32.0M	$30.0M	$12.0M	$9.0M

Latest News

Inovio Pharmaceuticals Files $300 Million Mixed Shelf Offering MT Newswires · Jul 2, 2026 INOVIO to Participate in Upcoming Scientific and Investor Conferences PR Newswire · May 28, 2026 Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances MarketBeat · May 25, 2026 INO Stock Edges Up After Hours As Partner Reports Success In Cervical Dysplasia Trial Stocktwits · May 21, 2026 Inovio Says China Partner Reported VGX-3100 Phase 3 Trial Met Primary Efficacy Endpoint in Cervical Dysplasia Patients MT Newswires · May 21, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-216.0M	$-216.0M	$-124.0M	$-104.0M	$-89.0M
Investing Cash Flow	$-177.0M	$109.0M	$87.0M	$104.0M	$14.0M
Financing Cash Flow	$2.0M	$-1.0M	$0	$0	$0
Net Cash Flow	$-180.0M	$-25.0M	$-32.0M	$52.0M	$-22.0M
Free Cash Flow	$-217.0M	$-217.0M	$-125.0M	$-105.0M	$-89.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-13.13
EV / EBITDA	-0.75
FCF Yield	-139.24%
Quick Ratio	1.04
Interest Coverage	—
Return 1Y	-10.69%
Return 3Y	-81.60%
Return 5Y	-98.82%

Ownership

Insiders Held0.42%

Institutions Held47.30%

Institutions Float Held47.49%

Institutional Holder	Shares	Report Date
FMR, LLC	9,339,614	2026-03-31
Janus Henderson Group PLC	3,308,406	2026-03-31
Vanguard Capital Management LLC	2,901,208	2026-03-31
Boxer Capital Management, LLC	2,370,122	2026-03-31
Shaw D.E. & Co., Inc.	2,212,819	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ABOS	$2.27	-0.66%	-1.17	$163.60M	0.00%
ACTU	$1.09	-5.22%	-2.73	$26.08M	0.00%
AGENAgenus Inc.	$6.06	+1.34%	3.46	$252.35M	0.00%
ALEC	$1.52	+0.33%	-1.58	$168.20M	0.00%
FATE	$2.31	-0.43%	-1.62	$269.25M	0.00%

About INO

INO is led by CEO Jacqueline E. Shea, employs 134 people, headquartered in US, publicly traded since 1998.

INO stock trades at $1.04 with a market capitalization of $55.73M. The stock is valued at a price-to-earnings (P/E) ratio of -2.73, price-to-book of 15.14, price-to-sales of 2122.74. Over the past 52 weeks the stock has ranged between $0.97 and $2.98, and currently trades 65.1% below its 52-week high.

On profitability, INO generates a return on equity (ROE) of -296.36%, return on capital employed of -362.50%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides